Efficacy and Safety Evaluation of Vi-sealer

NARecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

October 31, 2025

Conditions
Benign Gynecologic Neoplasm
Interventions
DEVICE

Vi-Sealer

using Reusable device, Vi-Sealer

DEVICE

Ligasure

using Ligasure

DEVICE

Other AHD

Using other AHDs such as Thunderbeat, Harmonic scalpel, Caiman®, Enseal, etc. except Ligasure

Trial Locations (1)

Unknown

RECRUITING

CHA Bundang Medical Center, Seongnam-si

All Listed Sponsors
lead

Hyun Park

OTHER